Flector System
Product Images NDC 71858-0405

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flector (NDC 71858-0405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Flector 01)

Chemical structure diagrams of diclofenac and epolamine, the active ingredients in FLECTOR (diclofenac epolamine topical system). The diclofenac structure includes two chlorine atoms and a carboxylate group, while the epolamine structure features a pyrrolidinol moiety with an ethanol side chain.*

FDA Label Image

Figure 1 (Flector 02)

A line graph comparing the percent of patients improved over a range of percent improvement from baseline. It displays data for diclofenac topical system versus placebo, showing a higher percent of patients improved with the diclofenac topical system across the improvement range.*

FDA Label Image

Figure 2 (Flector 03)

A line graph showing the percent of patients improved over a range of percent pain improvement from 10 to 100. The graph compares two groups: one treated with Diclofenac Topical System and the other with placebo. The Diclofenac group consistently shows higher percentages of patient improvement across the range compared to the placebo group.*

FDA Label Image

Figure 3 (Flector 04)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Topical System and placebo. The graph shows two lines with data points: one for Diclofenac Topical System and one for placebo, illustrating patient improvement trends over increasing percentages of improvement from baseline.*

FDA Label Image

Figure 4 (Flector 05)

A line graph comparing the percent of patients improved versus percent improvement from baseline for diclofenac topical system and placebo. The graph shows higher improvement percentages for the diclofenac topical system across the range compared to placebo.*

FDA Label Image

Principal Display Panel (30 Patch Pouch Carton)

FLECTOR topical system 1.3% (diclofenac epolamine) packaging label for 30 topical systems (10 cm x 14 cm each) by IBSA Pharma Inc. The label includes dosage directions, storage instructions, warnings, inactive ingredients, and detailed application steps with illustrations. The product is a prescription topical system designed for topical use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.